Cypherpunk Technologies Inc. (CYPH) vs Enanta Pharmaceuticals, Inc. (ENTA)

Cypherpunk Technologies Inc. and Enanta Pharmaceuticals, Inc. are both Biotechnology companies. Cypherpunk Technologies Inc. and Enanta Pharmaceuticals, Inc. are of similar size ($334.1M and $325.5M). Enanta Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Cypherpunk Technologies Inc. trades at 4.4×. Enanta Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 0.70% against 0.00%. Cypherpunk Technologies Inc. has the higher net margin (0.00% vs −96.9%) and the lower return on invested capital (−8.44% vs 0.00%). Across the 16 metrics below, Cypherpunk Technologies Inc. leads on 10 and Enanta Pharmaceuticals, Inc. on 6.

Valuation

Metric CYPH ENTA Biotechnology median
P/E 4.36 n/m 8.50
P/S 315.82 4.95 9.71
P/B 3.40 3.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 310.73 2.04 9.21
Earnings yield 22.96% (21.71%) (33.15%)
Free cash flow yield (4.44%) (11.44%) (25.50%)

Profitability

Metric CYPH ENTA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (89.99%) 0.00%
Net margin 0.00% (96.89%) 0.00%
Free cash flow margin 0.00% (56.60%) 0.00%
Return on equity (1.21%) (70.12%) (56.36%)
Return on assets (1.08%) (21.15%) (48.04%)
Return on invested capital (8.44%) 0.00% 0.00%

Growth

Metric CYPH ENTA Biotechnology median
Revenue growth (TTM) 0.00% 0.70% 6.02%
EPS growth (last fiscal year) 103.87% 29.93% 30.26%
Revenue growth, 5-year CAGR — (11.81%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYPH ENTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 79.19 3.76 4.72
Net debt to EBITDA 0.34 2.35 0.96

Dividend

Metric CYPH ENTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYPH ENTA Biotechnology median
Market cap 325.45m 334.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack